Atlas Trials

Efficacy Evaluation and Recurrence Monitoring of Therapy for Esophageal Squamous Cell Carcinoma Based on ctDNA-MRD.

Clinical trial NCT05900583 · UNKNOWN

Trial details

NCT number
NCT05900583
Sponsor
Guangdong Provincial People's Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Minimal Residual DiseaseEsophageal Squamous Cell Carcinoma
Start date
2023-06-01
Primary completion
2025-05-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.